| Title: | Risk of lymphoid malignancy associated with cancer predisposition genes |
| Journal: | Blood Cancer Journal |
| Published: | 19 Apr 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40253392/ |
| DOI: | https://doi.org/10.1038/s41408-025-01283-z |
| URL: | https://www.nature.com/articles/s41408-025-01283-z.pdf |
Publication 15806
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We investigated the prevalence of rare inherited pathogenic variants (PV) in 19 cancer predisposition genes regularly included on multi-gene panel testing based on NCCN guidelines and their association with the risk of lymphoid malignancies (LM) overall and by common lymphoma subtypes and multiple myeloma. The study population included newly diagnosed LM cases (N = 6990) and unrelated controls (N = 42,632), excluding individuals with a history of hematologic malignancy. Whole exome sequencing was performed on DNA from whole blood. PV were defined as loss-of-function (i.e., nonsense, frameshift, consensus splice sites) or identified as "pathogenic" or "likely pathogenic" in the ClinVar database. A total of 1816 (3.7%) individuals had a PV across the 19 genes, higher in cases (4.7%) than controls (3.5%). In controls, CHEK2 (1.0%), ATM (0.4%), BRCA2 (0.4%), and BRCA1 (0.3%) had the highest prevalence. ATM (odds ratio [OR] = 1.86, 95% confidence interval [CI]: 1.36-2.49), CHEK2 (OR = 1.74, 95% CI: 1.42-2.13) and TP53 (OR = 9.07, 95% CI: 4.51-18.87) were associated with increased risk of LM overall and were further validated in the UK Biobank. We observed heterogeneity in associations by LM subtype. These results demonstrate that several commonly tested cancer predisposition genes are associated with an increased risk of LM.</p>
10 Keywords
- Adult
- Aged
- Aged, 80 and over
- Case-Control Studies
- Female
- Genetic Predisposition to Disease
- Humans
- Lymphoma
- Male
- Middle Aged
107 Authors
- GNoncalo Abecasis
- Aris Baras
- Michael Cantor
- Giovanni Coppola
- Andrew Deubler
- Aris Economides
- Luca A. Lotta
- John D. Overton
- Jeffrey G. Reid
- Katherine Siminovitch
- Alan Shuldiner
- Christina Beechert
- Caitlin Forsythe
- Erin D. Fuller
- Zhenhua Gu
- Michael Lattari
- Alexander Lopez
- Maria Sotiropoulos Padilla
- Manasi Pradhan
- Kia Manoochehri
- Thomas D. Schleicher
- Louis Widom
- Sarah E. Wolf
- Ricardo H. Ulloa
- Amelia Averitt
- Nilanjana Banerjee
- Dadong Li
- Sameer Malhotra
- Ob Deepika Sharma
- Jeffrey Staples
- Xiaodong Bai
- Suganthi Balasubramanian
- Suying Bao
- Boris Boutkov
- Siying Chen
- Gisu Eom
- Lukas Habegger
- Alicia Hawes
- Shareef Khalid
- Olga Krasheninina
- Rouel Lanche
- Adam J. Mansfield
- Evan K. Maxwell
- George Mitra
- Mona Nafde
- Sean O'Keeffe
- Max Orelus
- Razvan Panea
- Tommy Polanco
- Ayesha Rasool
- William Salerno
- Jeffrey C. Staples
- Kathie Sun
- Goncalo Abecasis
- Joshua Backman
- Amy Damask
- Lee Dobbyn
- Manuel Allen Revez Ferreira
- Arkopravo Ghosh
- Christopher Gillies
- Lauren Gurski
- Eric Jorgenson
- Hyun Min Kang
- Michael Kessler
- Jack Kosmicki
- Alexander Li
- Nan Lin
- Daren Liu
- Adam Locke
- Jonathan Marchini
- Anthony Marcketta
- Joelle Mbatchou
- Arden Moscati
- Charles Paulding
- Carlo Sidore
- Eli Stahl
- Kyoko Watanabe
- Bin Ye
- Blair Zhang
- Andrey Ziyatdinov
- Ariane Ayer
- Aysegul Guvenek
- George Hindy
- Jan Freudenberg
- Jonas Bovijn
- Kavita Praveen
- Manav Kapoor
- Mary Haas
- Moeen Riaz
- Niek Verweij
- Olukayode Sosina
- Parsa Akbari
- Priyanka Nakka
- Sahar Gelfman
- Sujit Gokhale
- Tanima De
- Veera Rajagopal
- Gannie Tzoneva
- Juan Rodriguez-Flores
- Esteban Chen
- Marcus B. Jones
- Michelle G. LeBlanc
- Jason Mighty
- Lyndon J. Mitnaul
- Nirupama Nishtala
- Nadia Rana
- Jaimee Hernandez
1 Application
| Application ID | Title |
|---|---|
| 79864 | Genetics of Lymphomas |
Enabling scientific discoveries that improve human health